MERSANA THERAPEUTICS INC (MRSN) Stock Income Statement
NASDAQ:MRSN - Nasdaq - US59045L1061 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 34.01M | 40.50M | 36.85M | 26.58M | 40.00K | |||
| Operating Expenses | 110.85M | 113.83M | 207.81M | 230.35M | 168.90M | |||
| Research and Development | 72.67M | 73.02M | 148.27M | 173.39M | 132.01M | |||
| Selling, General, and Administrative Expenses | 38.18M | 40.81M | 59.54M | 56.96M | 36.89M | |||
| Operating Income | -76.85M | -73.34M | -170.96M | -203.77M | -168.86M | |||
| Interest Income/Expense | 3.26M | 4.56M | 8.00M | -450.00K | -1.20M | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | 0.00 | -8.71M | N/A | N/A | |||
| Income Before Taxes | -73.59M | -68.77M | -171.67M | -204.21M | -170.06M | |||
| Income Tax | N/A | 418.00K | N/A | N/A | N/A | |||
| Net Income | -74.01M | -69.19M | -171.67M | -204.21M | -170.06M | |||
| EBITDA | -75.33M | -71.71M | -169.44M | -202.84M | -168.00M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.60 | -0.56 | -1.48 | -2.18 | -2.41 | |||
| Non GAAP EPS | -0.59 | -0.56 | -1.42 | -2.19 | -2.40 | |||
| Statistics | ||||||||
| Profit Margin | -217.64% | -170.86% | -465.80% | -768.28% | -425150.00% | |||
| Operating Profit Margin | -225.98% | -181.09% | -463.86% | -766.63% | -422150.00% | |||
All data in USD